Surrogacy a $445 mn business in India
By The Economic Times,
The Economic Times
| 08. 25. 2008
Surrogacy in India is estimated to be a $445 million business with the country being the foremost in the world for the practice because of the low cost of treatment and the ready availability of women willing to rent their wombs to childless couples.
Lawyer Apurva Agarwal, during a three-day national moot court competition here, said that surrogacy has been a debatable issue in India and since it is a $445 million business, there is need for relevant laws.
"Sooner or later, we need to have the laws in place to protect the Indian surrogate mothers and also the foreigners who come here for treatment," she added.
"To further the cause of requisite laws for it (surrogacy), we organised the national moot court," said Agarwal.
At the competition that concluded at the Rizvi Law College here Sunday, a participant noted that in India, surrogacy costs about $12,000 compared to $70,000 in the US.
Then, British and American laws forbid surrogate mothers to charge a childless couple, while Indian laws do not prevent this, another participant noted.
Twenty-four of the best...
Related Articles
By Courtney Withers and Daryna Zadvirna, ABC News | 12.03.2025
Same-sex couples, single people, transgender and intersex West Australians will be able to access assisted reproductive technology (ART) and surrogacy, almost a decade after reforms were first promised.
The landmark legislation, which removes the requirement for people to demonstrate medical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
